Richard D. Sloan

1.5k total citations
37 papers, 1.2k citations indexed

About

Richard D. Sloan is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Richard D. Sloan has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Virology, 20 papers in Infectious Diseases and 13 papers in Immunology. Recurrent topics in Richard D. Sloan's work include HIV Research and Treatment (28 papers), HIV/AIDS drug development and treatment (16 papers) and Biochemical and Molecular Research (6 papers). Richard D. Sloan is often cited by papers focused on HIV Research and Treatment (28 papers), HIV/AIDS drug development and treatment (16 papers) and Biochemical and Molecular Research (6 papers). Richard D. Sloan collaborates with scholars based in Canada, United Kingdom and China. Richard D. Sloan's co-authors include Mark A. Wainberg, Daniel A. Donahue, Björn D. Kuhl, Tamara Bar-Magen, Hongtao Xu, Peter K. Quashie, Jordan S. Taylor, Eugene L. Asahchop, Cécile Tremblay and Thibault Mésplède and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Richard D. Sloan

36 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard D. Sloan Canada 21 785 650 377 292 278 37 1.2k
Peter K. Cheung Canada 17 638 0.8× 567 0.9× 369 1.0× 254 0.9× 359 1.3× 29 1.3k
George M. Shaw United States 5 1.1k 1.3× 673 1.0× 334 0.9× 602 2.1× 287 1.0× 6 1.5k
Yoshiyuki Yokomaku Japan 20 699 0.9× 654 1.0× 366 1.0× 193 0.7× 283 1.0× 60 1.1k
Ritu Goila-Gaur United States 16 1.3k 1.6× 868 1.3× 575 1.5× 384 1.3× 494 1.8× 18 1.6k
Masashi Tatsumi Japan 18 544 0.7× 474 0.7× 335 0.9× 258 0.9× 148 0.5× 63 1.1k
Fiona Wightman Australia 17 944 1.2× 568 0.9× 247 0.7× 490 1.7× 326 1.2× 24 1.3k
M Groenink Netherlands 13 1.2k 1.6× 833 1.3× 251 0.7× 466 1.6× 200 0.7× 17 1.4k
Beatriz Pacheco United States 17 743 0.9× 461 0.7× 212 0.6× 371 1.3× 277 1.0× 32 1.0k
Zhihai Si United States 17 1.1k 1.4× 528 0.8× 553 1.5× 558 1.9× 319 1.1× 19 1.4k
Zelda Euler Netherlands 15 956 1.2× 376 0.6× 298 0.8× 615 2.1× 170 0.6× 23 1.2k

Countries citing papers authored by Richard D. Sloan

Since Specialization
Citations

This map shows the geographic impact of Richard D. Sloan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Sloan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Sloan more than expected).

Fields of papers citing papers by Richard D. Sloan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard D. Sloan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Sloan. The network helps show where Richard D. Sloan may publish in the future.

Co-authorship network of co-authors of Richard D. Sloan

This figure shows the co-authorship network connecting the top 25 collaborators of Richard D. Sloan. A scholar is included among the top collaborators of Richard D. Sloan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard D. Sloan. Richard D. Sloan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mak, N. K., Jingyan Liu, Dan Zhang, et al.. (2024). Alternative splicing expands the antiviral IFITM repertoire in Chinese rufous horseshoe bats. PLoS Pathogens. 20(12). e1012763–e1012763. 1 indexed citations
2.
3.
McKnight, Áine, et al.. (2023). The innate immune factor RPRD2/REAF and its role in the Lv2 restriction of HIV. mBio. 14(6). e0257221–e0257221. 3 indexed citations
4.
Zhu, Kaixiang, Xuexiao Jin, Zhexu Chi, et al.. (2021). Priming of NLRP3 inflammasome activation by Msn kinase MINK1 in macrophages. Cellular and Molecular Immunology. 18(10). 2372–2382. 26 indexed citations
5.
Gibbons, Joseph M., Wing-Yiu Jason Lee, Christopher E. Jones, et al.. (2019). HIV-1 Accessory Protein Vpr Interacts with REAF/RPRD2 To Mitigate Its Antiviral Activity. Journal of Virology. 94(4). 12 indexed citations
6.
Lee, Wing-Yiu Jason, et al.. (2018). IFITM proteins inhibit HIV-1 protein synthesis. Scientific Reports. 8(1). 14551–14551. 51 indexed citations
7.
Quashie, Peter K., Thibault Mésplède, Ying-Shan Han, et al.. (2014). Biochemical Analysis of the Role of G118R-Linked Dolutegravir Drug Resistance Substitutions in HIV-1 Integrase. Antimicrobial Agents and Chemotherapy. 58(6). 3580–3580. 4 indexed citations
8.
Quan, Yudong, Hongtao Xu, Victor G. Kramer, et al.. (2014). Identification of an env-defective HIV-1 mutant capable of spontaneous reversion to a wild-type phenotype in certain T-cell lines. Virology Journal. 11(1). 177–177. 4 indexed citations
9.
Schader, Susan M., Richard D. Sloan, Maureen Oliveira, et al.. (2013). HIV-1 Subtype Variability in Vif Derived from Molecular Clones Affects APOBEC3G-Mediated Host Restriction. Intervirology. 56(4). 258–264. 9 indexed citations
10.
Quashie, Peter K., Richard D. Sloan, & Mark A. Wainberg. (2012). Novel therapeutic strategies targeting HIV integrase. BMC Medicine. 10(1). 34–34. 57 indexed citations
11.
Sloan, Richard D., et al.. (2011). Transcription of Preintegrated HIV-1 cDNA Modulates Cell Surface Expression of Major Histocompatibility Complex Class I via Nef. Journal of Virology. 85(6). 2828–2836. 14 indexed citations
12.
Kuhl, Björn D., Richard D. Sloan, Daniel A. Donahue, Chen Liang, & Mark A. Wainberg. (2011). Vpu-mediated tetherin antagonism of ongoing HIV-1 infection in CD4+ T-cells is not directly related to the extent of tetherin cell surface downmodulation. Virology. 417(2). 353–361. 7 indexed citations
13.
Kuhl, Björn D., Daniel A. Donahue, Richard D. Sloan, et al.. (2011). The HIV-1 Vpu Viroporin Inhibitor BIT225 Does Not Affect Vpu-Mediated Tetherin Antagonism. PLoS ONE. 6(11). e27660–e27660. 20 indexed citations
14.
Sloan, Richard D. & Mark A. Wainberg. (2011). The role of unintegrated DNA in HIV infection. Retrovirology. 8(1). 52–52. 111 indexed citations
15.
Bar-Magen, Tamara, Daniel A. Donahue, Björn D. Kuhl, et al.. (2010). HIV-1 subtype B and C integrase enzymes exhibit differential patterns of resistance to integrase inhibitors in biochemical assays. AIDS. 24(14). 2171–2179. 52 indexed citations
16.
Sloan, Richard D., Daniel A. Donahue, Björn D. Kuhl, Tamara Bar-Magen, & Mark A. Wainberg. (2010). Expression of Nef from unintegrated HIV-1 DNA downregulates cell surface CXCR4 and CCR5 on T-lymphocytes. Retrovirology. 7(1). 44–44. 31 indexed citations
17.
Kuhl, Björn D., Richard D. Sloan, Daniel A. Donahue, et al.. (2010). Tetherin restricts direct cell-to-cell infection of HIV-1. Retrovirology. 7(1). 115–115. 82 indexed citations
18.
Bar-Magen, Tamara, Richard D. Sloan, Daniel A. Donahue, et al.. (2009). Comparative biochemical analysis of HIV-1 subtype B and C integrase enzymes. Retrovirology. 6(1). 103–103. 40 indexed citations
19.
Sloan, Richard D., Dieter Klein, Nicola Logan, et al.. (2009). Feline immunodeficiency virus env gene evolution in experimentally infected cats. Veterinary Immunology and Immunopathology. 134(1-2). 96–106. 18 indexed citations
20.
Sloan, Richard D., Angela Strang, Mary Ramsay, & Chong‐Gee Teo. (2009). Genotyping of acute HBV isolates from England, 1997–2001. Journal of Clinical Virology. 44(2). 157–160. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter K. Cheung Breakdown of academic impact, for papers by George M. Shaw Breakdown of academic impact, for papers by Yoshiyuki Yokomaku Breakdown of academic impact, for papers by Ritu Goila-Gaur Breakdown of academic impact, for papers by Masashi Tatsumi Breakdown of academic impact, for papers by Fiona Wightman Breakdown of academic impact, for papers by M Groenink Breakdown of academic impact, for papers by Beatriz Pacheco Breakdown of academic impact, for papers by Zhihai Si Breakdown of academic impact, for papers by Zelda Euler
Rankless by CCL
2026